<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="HFA071E3F25614027BD5D755C86834CCE" key="H" public-private="public"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>115 HR 4899 IH: Access to Substance Abuse Treatment Act of 2018</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2018-01-30</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">115th CONGRESS</congress><session display="yes">2d Session</session><legis-num display="yes">H. R. 4899</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20180130">January 30, 2018</action-date><action-desc><sponsor name-id="C001090">Mr. Cartwright</sponsor> (for himself, <cosponsor name-id="P000604">Mr. Payne</cosponsor>, and <cosponsor name-id="N000147">Ms. Norton</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Public Health Service Act to provide grants for treatment of heroin, opioids, cocaine,
			 methamphetamine, 3,4-methylenedioxymethamphetamine (ecstasy), and
			 phencyclidine (PCP) abuse, and for other purposes.</official-title></form>
	<legis-body id="HD728396822174C8A9B4AEC34CD7E5317" style="OLC">
 <section id="HAC547ED901A2403092CD2F5ABA0E2D1D" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Access to Substance Abuse Treatment Act of 2018</short-title></quote>.</text> </section><section id="HA782B080E31A411B8B39F4F4C9D6CD7C"><enum>2.</enum><header>Purpose</header><text display-inline="no-display-inline">It is the purpose of this Act to—</text>
 <paragraph id="HDE6E99E4C22F4614BDD8547F1C042EE6"><enum>(1)</enum><text display-inline="yes-display-inline">reduce crime and improve public safety by making treatment for heroin, opioids, cocaine, methamphetamine, 3,4-methylene­dioxy­meth­am­phet­amine (ecstasy), and phen­cy­cli­dine (PCP) abuse available to every American who needs it;</text>
 </paragraph><paragraph id="H0F8132AE77B3434AAE10F2951DAEEE5E"><enum>(2)</enum><text>keep families together by encouraging alternatives to incarceration for nonviolent drug law offenses;</text>
 </paragraph><paragraph id="H0E1AF870CE3A413586AD30225693FC84"><enum>(3)</enum><text display-inline="yes-display-inline">help identify root causes and most effective treatment methods for heroin, opioids, cocaine, methamphetamine, 3,4-methylene­dioxy­meth­am­phet­amine, and phen­cy­cli­dine abuse; and</text>
 </paragraph><paragraph id="H674A62B12AEE4B7D9302C03222F2251E"><enum>(4)</enum><text display-inline="yes-display-inline">expand research into cutting-edge treatment methods for stimulant abuse.</text> </paragraph></section><section id="HAC9F7586452B4DFDB7874701885552AB"><enum>3.</enum><header>Heroin, opioids, cocaine, methamphetamine, 3,4-methylene­dioxy­meth­am­phet­amine (ecstasy), and phen­cy­cli­dine (PCP) treatment and wrap-around programs</header><text display-inline="no-display-inline">Subpart 1 of part B of title V of the Public Health Service Act is amended by inserting after section 514B (<external-xref legal-doc="usc" parsable-cite="usc/42/290bb-10">42 U.S.C. 290bb–10</external-xref>) the following new sections:</text>
			<quoted-block display-inline="no-display-inline" id="HC765BB5E8865429183208A86B2E39859" style="OLC">
				<section id="HBCA4897759BD4FA6B3BAF3678AFAF100"><enum>514C.</enum><header>Initiative to increase heroin, opioids, cocaine, methamphetamine, ecstasy, and PCP treatment
			 capacity</header>
 <subsection id="H9A5D5BB79C9346509BFB86F5B1E6E7BF"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">The Secretary may make grants to State, local, and tribal governments for the purpose of increasing the availability of treatment for heroin, opioids, cocaine, methamphetamine, 3,4-methylene­dioxy­meth­am­phet­amine (ecstasy), and phen­cy­cli­dine (PCP) abuse.</text>
					</subsection><subsection id="HD742B6FE95184DBBBEDABDE76769B5DB"><enum>(b)</enum><header>Requirements</header>
 <paragraph id="HAA16E71E67EA4C6C944209EE5BD1A727"><enum>(1)</enum><header>In general</header><text>To seek a grant under <internal-xref idref="H9A5D5BB79C9346509BFB86F5B1E6E7BF" legis-path="514C.(a)">subsection (a)</internal-xref>, a State, local, or tribal government shall submit an application to the Secretary at such time, in such manner, and containing such information and assurances as the Secretary may require.</text>
 </paragraph><paragraph display-inline="no-display-inline" id="HE7EB1A9CE8654DA5BE6AEAD77A8CA6C5"><enum>(2)</enum><header>Use of grant funds</header><text display-inline="yes-display-inline">The grants made under <internal-xref idref="H9A5D5BB79C9346509BFB86F5B1E6E7BF" legis-path="514C.(a)">subsection (a)</internal-xref> may only be used to—</text> <subparagraph id="H6E4D44DCD8944B1EB8725EB348B9006C"><enum>(A)</enum><text>build treatment centers;</text>
 </subparagraph><subparagraph id="H5A01C6EC779743A8BDC60E2FE950E8B2"><enum>(B)</enum><text>expand existing treatment centers;</text> </subparagraph><subparagraph id="H0008580A5606493385E04BF2803A4862"><enum>(C)</enum><text>hire treatment professionals;</text>
 </subparagraph><subparagraph id="HD2980E83979741D4B14E708FC82E6880"><enum>(D)</enum><text display-inline="yes-display-inline">provide training and education to substance abuse professionals, medical professionals, and educators related to the treatment of heroin, opioids, cocaine, methamphetamine, 3,4-methylene­dioxy­meth­am­phet­amine, and phen­cy­cli­dine abuse; and</text>
 </subparagraph><subparagraph id="H55275BEF089E4F01AC843E39D899A607"><enum>(E)</enum><text>engage in other activities that the Secretary has determined are relevant to the purpose of the grants under <internal-xref idref="H9A5D5BB79C9346509BFB86F5B1E6E7BF" legis-path="514C.(a)">subsection (a)</internal-xref>.</text>
 </subparagraph></paragraph></subsection><subsection id="H81C9BCC924424D60897C18C158CA8221"><enum>(c)</enum><header>Authorization of appropriations</header><text display-inline="yes-display-inline">There are authorized to be appropriated such sums as may be necessary to carry out this section for fiscal years 2019 through 2023.</text>
					</subsection></section><section commented="no" id="HC14251014FE240F19015575F31F5A8A9"><enum>514D.</enum><header>Heroin, opioids, cocaine, methamphetamine, ecstasy, and PCP abuse treatment vouchers for
			 underserved populations</header>
 <subsection commented="no" id="HF567B3BD7BE342A986A95E79DD45811E"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">The Secretary may make grants to State, local, and tribal governments and nonprofit entities to provide vouchers to individuals in underserved populations for authorized services related to the treatment of such individuals for heroin, opioids, cocaine, methamphetamine, 3,4-methylene­dioxy­meth­am­phet­amine (ecstasy), and phen­cy­cli­dine (PCP) abuse.</text>
					</subsection><subsection id="HCE8563273C0C424E970A33E680A2A9DA"><enum>(b)</enum><header>Requirements</header>
 <paragraph commented="no" id="H8FA9D340AABD46C683613456C47F4F8D"><enum>(1)</enum><header>Application</header><text>To seek a grant under <internal-xref idref="HF567B3BD7BE342A986A95E79DD45811E" legis-path="514D.(a)">subsection (a)</internal-xref>, a State, local, or tribal government or a nonprofit entity shall submit an application to the Secretary at such time, in such manner, and containing such information and assurances as the Secretary may require, including a description of the method that such State, government, or entity will use—</text>
 <subparagraph id="H0EAD5554280547BA9B4B8E5A0D8101D2"><enum>(A)</enum><text display-inline="yes-display-inline">to identify individuals who would benefit from treatment for heroin, opioids, cocaine, methamphetamine, 3,4-methylene­dioxy­meth­am­phet­amine, or phen­cy­cli­dine abuse;</text>
 </subparagraph><subparagraph id="H4EF146E1CB314E0AA16A17F4B032AF56"><enum>(B)</enum><text>to identify if such individuals are in underserved populations; and</text> </subparagraph><subparagraph id="H89DA4504B6C54D89A4ED35EE9D04C433"><enum>(C)</enum><text>to provide vouchers to such individuals in such populations.</text>
 </subparagraph></paragraph><paragraph id="H624C9B94F89345C08F889B7781606F93"><enum>(2)</enum><header>Preservation of choice</header><text display-inline="yes-display-inline">A recipient of a grant under this section may not restrict the ability of an individual receiving a voucher under this section to use the voucher to pay for authorized services furnished by any provider of authorized services, so long as the provider of such services meets all applicable State licensure or certification requirements regarding the provision of such services.</text>
 </paragraph><paragraph id="H9098F90EEC754B139C5141410B39734E"><enum>(3)</enum><header>Duration of award</header><text>With respect to a grant under this section, the period during which payments under such grant are made to the grant recipient may not exceed five years.</text>
 </paragraph><paragraph id="H6B573612F1D8476A8C35633A80591A3E"><enum>(4)</enum><header>Matching funds</header><text display-inline="yes-display-inline">The Secretary may require that recipients of grants under this section provide non-Federal matching funds, as determined appropriate by the Secretary, to ensure the commitment of the grant recipients to the provision of vouchers for treatment to individuals who use heroin, opioids, cocaine, methamphetamine, 3,4-methylene­dioxy­meth­am­phet­amine, or phen­cy­cli­dine. Such non-Federal matching funds may be provided directly or through donations from public or private entities and may be in cash or in-kind, fairly evaluated, including property, equipment, or services.</text>
 </paragraph><paragraph id="H2BF5A134ABCD4B0C9967BCD968D50B27"><enum>(5)</enum><header>Maintenance of effort</header><text display-inline="yes-display-inline">The Secretary may require that grant recipients under this section agree to maintain expenditures of non-Federal amounts for authorized services related to the treatment of heroin, opioids, cocaine, methamphetamine, 3,4-methylene­dioxy­meth­am­phet­amine, and phen­cy­cli­dine abuse at a level that is not less than the level of such expenditures maintained by the recipient for the fiscal year preceding the fiscal year for which the entity receives such a grant.</text>
						</paragraph></subsection><subsection commented="no" id="HA1F4BA90A9054AEAA4DB230C05AF9208"><enum>(c)</enum><header>Report</header>
 <paragraph commented="no" id="HF449F4FDFABF4347A8AB6CB05E462310"><enum>(1)</enum><header>In general</header><text>Not later than December 1, 2019, and annually thereafter, the Secretary shall submit a report to the Congress on the grants under subsection (a).</text>
 </paragraph><paragraph commented="no" id="H621CEC0FC98B4323A0141C29498F3639"><enum>(2)</enum><header>Contents of report</header><text display-inline="yes-display-inline">The report under paragraph (1) shall contain an evaluation of the effectiveness of the grants made under subsection (a) in improving access to heroin, opioids, cocaine, methamphetamine, 3,4-methylene­dioxy­meth­am­phet­amine, and phen­cy­cli­dine treatment for underserved populations.</text>
 </paragraph></subsection><subsection id="HAC6B366C790B4C4DA8BD8E1E9EE0F600"><enum>(d)</enum><header>Definitions</header><text display-inline="yes-display-inline">For purposes of this section:</text> <paragraph id="H19ED149DC9F7492A97913D83DAEEA73D"><enum>(1)</enum><header>Authorized services</header><text display-inline="yes-display-inline">The term <term>authorized services</term> means—</text>
 <subparagraph id="HE8329E7AC38D4CB5A19465F881ACB69A"><enum>(A)</enum><text display-inline="yes-display-inline">treatment for heroin, opioids, cocaine, methamphetamine, 3,4-methylene­dioxy­meth­am­phet­amine, or phen­cy­cli­dine abuse, including individual, group, and family counseling regarding such abuse;</text>
 </subparagraph><subparagraph id="HA686953991B04294B48CEF8176DF1ECE"><enum>(B)</enum><text>follow-up services to prevent an individual from relapsing into such abuse;</text> </subparagraph><subparagraph id="HD59770D1CAA04560A94DAF19A56FFF77"><enum>(C)</enum><text>wrap-around services, as such term is defined in section 514E(e)(4); and</text>
 </subparagraph><subparagraph id="HB7F019001E4B426EAF9ABFA61E38C966"><enum>(D)</enum><text>any additional services specified by the Secretary.</text> </subparagraph></paragraph><paragraph id="H1727CFF1A9314B4196E025FE66F31346"><enum>(2)</enum><header>Underserved population</header><text display-inline="yes-display-inline">The term <term>underserved population</term> means a population of individuals who cannot access appropriate substance abuse treatment (including comprehensive substance abuse treatment) due to financial, geographical, language, socioeconomic, or cultural barriers.</text>
 </paragraph></subsection><subsection commented="no" id="H77A9D7D9DD7E44D394C6398D197999FA"><enum>(e)</enum><header>Authorization of appropriations</header><text display-inline="yes-display-inline">There are authorized to be appropriated such sums as may be necessary to carry out this section for fiscal years 2019 through 2023.</text>
					</subsection></section><section id="H3E3B522A9F414CB4944BB09A6E4E1A97"><enum>514E.</enum><header>Comprehensive wrap-around heroin, opioids, cocaine, methamphetamine,
			 3,4-methylene­dioxy­meth­am­phet­amine (ecstasy), and phen­cy­cli­dine
			 (PCP) treatment services</header>
 <subsection display-inline="no-display-inline" id="H102FC34C56E64C0C87C3102F081AD79D"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">The Secretary may make grants to public, private, and nonprofit entities, Indian tribes, and tribal organizations to establish programs to provide for and coordinate the provision of wrap-around services to heroin, opioids, cocaine, methamphetamine, 3,4-methylene­dioxy­meth­am­phet­amine, or phen­cy­cli­dine-affected individuals.</text>
 </subsection><subsection id="H4D6F4773EDF444D0A5885C7958757CE4"><enum>(b)</enum><header>Minimum qualifications for receipt of award</header><text display-inline="yes-display-inline">To seek a grant under <internal-xref idref="H102FC34C56E64C0C87C3102F081AD79D" legis-path="514E.(a)">subsection (a)</internal-xref>, a public, private, or nonprofit entity, an Indian tribe, or a tribal organization shall submit an application to the Secretary at such time, in such manner, and containing such information and assurances as the Secretary may require, including assurances to the satisfaction of the Secretary that—</text>
 <paragraph id="HE3534342F5EA4339B28B2C24FB9DD557"><enum>(1)</enum><text>the applicant has the capacity to carry out a program described in <internal-xref idref="H102FC34C56E64C0C87C3102F081AD79D" legis-path="514E.(a)">subsection (a)</internal-xref>;</text> </paragraph><paragraph id="H74DC9063177D493D91775710D9B62D28"><enum>(2)</enum><text>the applicant has entered into agreements with entities in the community involved, through which the applicant will provide wrap-around services; and</text>
 </paragraph><paragraph id="H5A8CBD80F32241649E78352588D6C69D"><enum>(3)</enum><text>the applicant, or any entity through which the applicant will provide such services, meets all applicable State licensure or certification requirements regarding the provision of such services.</text>
 </paragraph></subsection><subsection commented="no" id="HA6C5B4F084E748E4BC1F03A8FA4CEBC0"><enum>(c)</enum><header>Priority for grant distribution</header><text display-inline="yes-display-inline">In making grants under this section, the Secretary shall give priority to applications for programs that serve communities with a high or increasing rate of heroin, opioids, cocaine, methamphetamine, 3,4-methylene­dioxy­meth­am­phet­amine, or phen­cy­cli­dine abuse or addiction, as specified by the Secretary.</text>
 </subsection><subsection id="HB30075599AA34D8689F8D76F6DC161F9"><enum>(d)</enum><header>Reports</header><text display-inline="yes-display-inline">For each year that a public, private, or nonprofit entity, Indian tribe, or tribal organization receives a grant under subsection (a) for a program, such entity, tribe, or organization shall submit to the Secretary a report on the results and effectiveness of the program.</text>
 </subsection><subsection id="H54E5788AF2BB4E19BCDFE6BFA008416B"><enum>(e)</enum><header>Definitions</header><text>For purposes of this section:</text> <paragraph id="HBD69A99F68C14581BCAAA5994EDEEE3A"><enum>(1)</enum><header>Heroin, opioids, cocaine, methamphetamine, 3,4-methylene­dioxy­meth­am­phet­amine, or phen­cy­cli­dine-affected individual</header><text>The term <term>heroin, opioids, cocaine, methamphetamine, 3,4-methylene­dioxy­meth­am­phet­amine, or phen­cy­cli­dine-affected individual</term> means an individual who—</text>
							<subparagraph id="H91E566131F5E433EAE9E36824D947CAB"><enum>(A)</enum>
 <clause commented="no" display-inline="yes-display-inline" id="H1C847186C7D04ED4B2743A13FBC3A236"><enum>(i)</enum><text display-inline="yes-display-inline">resided in a residential inpatient treatment facility for the treatment of heroin, opioids, cocaine, methamphetamine, 3,4-methylene­dioxy­meth­am­phet­amine, or phen­cy­cli­dine abuse or addiction; or</text>
 </clause><clause id="HE54FACE5A08848759F26155C754E7DBC" indent="up1"><enum>(ii)</enum><text display-inline="yes-display-inline">received treatment for heroin, opioids, cocaine, methamphetamine, 3,4-methylene­dioxy­meth­am­phet­amine, or phen­cy­cli­dine abuse or addiction from an intensive outpatient treatment facility; and</text>
 </clause></subparagraph><subparagraph display-inline="no-display-inline" id="HF2C880DDE5214466AAD4A06D93ABAC26"><enum>(B)</enum><text>after successful completion of such treatment reenters the community.</text> </subparagraph></paragraph><paragraph id="H5BB8843640794CB5B348371A14CF5FAC"><enum>(2)</enum><header>Intensive outpatient treatment facility</header><text>The term <term>intensive outpatient treatment facility</term> means a facility that provides treatment for substance abuse and that, with respect to an individual receiving such treatment—</text>
 <subparagraph id="H1E4B0DCFED054ED4B3FC6DE4548D68A6"><enum>(A)</enum><text display-inline="yes-display-inline">provides a minimum of seven hours of treatment for substance abuse during a week;</text> </subparagraph><subparagraph id="HC377332BA3CA47558C91BA3530EFC29B"><enum>(B)</enum><text>provides regularly scheduled treatment sessions within a structured program; and</text>
 </subparagraph><subparagraph id="H37AA0322DFC24AD6A27E1D93E0819829"><enum>(C)</enum><text>ensures that the treatment sessions are led by health professionals or clinicians.</text> </subparagraph></paragraph><paragraph display-inline="no-display-inline" id="H5DE0DC967C604641A12434D25A1DB904"><enum>(3)</enum><header>Residential inpatient treatment facility</header><text>The term <term>residential inpatient treatment facility</term> means a facility that provides treatment for substance abuse in which health professionals and clinicians provide a planned regimen of 24-hour professionally directed evaluation, care, and treatment for such substance abuse in an inpatient setting, including 24-hour observation and monitoring.</text>
 </paragraph><paragraph display-inline="no-display-inline" id="H7A8AAA573C7E4B7DA9B8229203055998"><enum>(4)</enum><header>Wrap-around services</header><text display-inline="yes-display-inline">The term <term>wrap-around services</term> means, with respect to a heroin, opioids, cocaine, methamphetamine, 3,4-methylene­dioxy­meth­am­phet­amine, or phen­cy­cli­dine-affected individual, the following services:</text>
 <subparagraph id="H161EF5DECAD3423FB792EA6C88FC61DF"><enum>(A)</enum><text>Medical services.</text> </subparagraph><subparagraph id="HB605B762BE614601896C7BF849E0E4AC"><enum>(B)</enum><text>Dental services.</text>
 </subparagraph><subparagraph id="H0EA1AFF6F5B14512879E6560B7B3DB0D"><enum>(C)</enum><text>Mental health services.</text> </subparagraph><subparagraph id="H69A62DE9B8EB42FF93BE289DE0C42ADF"><enum>(D)</enum><text>Child care services.</text>
 </subparagraph><subparagraph id="HD45BC618520E4064B23D770706655BF3"><enum>(E)</enum><text>Job training services.</text> </subparagraph><subparagraph id="HA6FADB7FA7B149C7AA723C859EC85E7F"><enum>(F)</enum><text>Housing assistance.</text>
 </subparagraph><subparagraph id="HC7E35FFD06E74F9CB0C2AB87354F6AF3"><enum>(G)</enum><text>Training in parenting.</text> </subparagraph><subparagraph id="H7A11CAFBE17647DD8A9D3480FCE0EF65"><enum>(H)</enum><text display-inline="yes-display-inline">Prevention services for family members, with respect to heroin, opioids, cocaine, methamphetamine, 3,4-methylene­dioxy­meth­am­phet­amine, and phen­cy­cli­dine abuse or addiction.</text>
 </subparagraph><subparagraph id="H34032D60B34D40969EE65DE8EDA64B37"><enum>(I)</enum><text>Transportation assistance services for purposes of participation in the services listed in subparagraphs (A) through (H).</text>
 </subparagraph></paragraph></subsection><subsection id="HD45E3F8451B34BE08226A319E96C2015"><enum>(f)</enum><header>Authorization of appropriations</header><text display-inline="yes-display-inline">There are authorized to be appropriated such sums as may be necessary to carry out this section for fiscal years 2019 through 2023.</text></subsection></section><after-quoted-block>.</after-quoted-block></quoted-block>
		</section><section id="H6DED598840684E268F950AE0636FCB8B"><enum>4.</enum><header>Extension and expansion of residential treatment program for pregnant and postpartum women to
 include caregiver parents</header><text display-inline="no-display-inline">Section 508 of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/290bb-1">42 U.S.C. 290bb–1</external-xref>) is amended—</text> <paragraph commented="no" id="HF99AED2ECEAC46F3A0F4FE1739CCD933"><enum>(1)</enum><text>in the heading, by striking <quote><header-in-text level="section" style="traditional">pregnant and postpartum women</header-in-text></quote> and inserting <quote><header-in-text level="section" style="traditional">caregiver parents, including pregnant women</header-in-text></quote>;</text>
 </paragraph><paragraph commented="no" id="H8308032415C140C8A8A61EFAB94BE13A"><enum>(2)</enum><text>in subsection (a)—</text> <subparagraph commented="no" id="HA9854D42BEAD43B7A5AB1F5D1F88FC47"><enum>(A)</enum><text>in the matter preceding paragraph (1)—</text>
 <clause commented="no" id="HED054D7C464D423D98E1A87414C69D7F"><enum>(i)</enum><text>by inserting <quote>, Indian tribes, and tribal organizations</quote> after <quote>nonprofit private entities</quote>; and</text> </clause><clause commented="no" id="H10B708EDC4E24EF3ACB7487C3918BF9C"><enum>(ii)</enum><text>by striking <quote>pregnant and postpartum women treatment for substance abuse</quote> and inserting <quote>caregiver parents, including pregnant women, treatment for substance abuse (including treatment for addiction to heroin, opioids, cocaine, methamphetamine, 3,4-methylene­dioxy­meth­am­phet­amine (ecstasy), or phen­cy­cli­dine (PCP))</quote>;</text>
 </clause></subparagraph><subparagraph commented="no" id="HCB033BF804BA49559A6BA3CB09FD9760"><enum>(B)</enum><text>in each of paragraphs (1), (2), and (3), by striking <quote>the women</quote> and inserting <quote>such parents</quote> each place it appears; and</text> </subparagraph><subparagraph commented="no" id="H24F5B7A514364BF48A5BBAFA6E3A4DE3"><enum>(C)</enum><text>in paragraph (3), by inserting <quote>supplemental</quote> before <quote>services</quote>;</text>
 </subparagraph></paragraph><paragraph commented="no" id="H40902710F4B64B53A14EE019EFF7C062"><enum>(3)</enum><text>in subsection (b)—</text> <subparagraph commented="no" id="H66269FDAEEDD4E7298BA60C336F93828"><enum>(A)</enum><text>in paragraph (1), by inserting <quote>, Indian tribes, or tribal organizations</quote> after <quote>nonprofit private entities</quote>; and</text>
 </subparagraph><subparagraph commented="no" id="H61684F9900944B688EB07F912EFFF0A7"><enum>(B)</enum><text>in paragraph (2)—</text> <clause commented="no" id="H168582019C8B47ECB6525E4ADAF8F5D6"><enum>(i)</enum><text>by striking <quote>the services</quote> and inserting <quote>such services</quote>; and</text>
 </clause><clause commented="no" id="H93ECF30431E8443EA99A28CD29FC3BCF"><enum>(ii)</enum><text>by striking <quote>woman</quote> and inserting <quote>caregiver parent</quote>;</text> </clause></subparagraph></paragraph><paragraph commented="no" id="H07F956469AFD4269B7B6021718FD8868"><enum>(4)</enum><text>in subsection (c)—</text>
 <subparagraph commented="no" id="HF84DDC8B1BE7427E8748D7B6E0846540"><enum>(A)</enum><text display-inline="yes-display-inline">in paragraph (1), by striking <quote>eligible woman</quote> and inserting <quote>eligible caregiver parent</quote>; and</text> </subparagraph><subparagraph id="HC93EBAA52E1F4F04A09CDE9B64764168"><enum>(B)</enum><text>by striking <quote>the women</quote> and <quote>the woman</quote> each place either term appears and inserting <quote>such parent</quote>;</text>
 </subparagraph></paragraph><paragraph commented="no" id="H724CC83FFAAA4D57B57CDD20CB4837B7"><enum>(5)</enum><text>in subsection (d)—</text> <subparagraph commented="no" id="HC0D1C20C0A7649E09BB31F0DF7F885EC"><enum>(A)</enum><text display-inline="yes-display-inline">in the matter proceeding paragraph (1), by striking <quote>woman</quote> and inserting <quote>caregiver parent</quote>;</text>
 </subparagraph><subparagraph commented="no" id="H118658BB8465460CBCEC174C2A81DE45"><enum>(B)</enum><text display-inline="yes-display-inline">in paragraphs (3) and (4), by striking <quote>the woman</quote> and inserting <quote>such parent</quote> each place it appears;</text> </subparagraph><subparagraph commented="no" id="HBFE1A1328300452D8291DE731725945A"><enum>(C)</enum><text>in paragraph (9)—</text>
 <clause id="HF5E887BDE9D449918D97C52876703C85"><enum>(i)</enum><text display-inline="yes-display-inline">by striking <quote>the women</quote> and inserting <quote>such parent</quote> each place it appears;</text> </clause><clause id="H1C46B7C241C9413A9F6D0F9B182B63B4"><enum>(ii)</enum><text>by striking <quote>units</quote> and inserting <quote>unit</quote>; and</text>
 </clause><clause id="H412F66765A3B4834AFCEF0F89F957E8A"><enum>(iii)</enum><text>by striking <quote>of parents</quote> and inserting <quote>of the parents of such parent</quote>;</text> </clause></subparagraph><subparagraph id="H6364FB8D74904426BC89DDDFEC4A9EF6"><enum>(D)</enum><text>in paragraph (10), by inserting <quote>, Indian tribes, or tribal organizations</quote> after <quote>entities</quote>; and</text>
 </subparagraph><subparagraph id="HEA966CEE7C6D44B8A24373160D7BF460"><enum>(E)</enum><text>in paragraph (11)—</text> <clause id="H781FA8A8D71248B69C72EBF8E9E8AF45"><enum>(i)</enum><text display-inline="yes-display-inline">by striking <quote>the women</quote> and inserting <quote>such parent</quote>; and</text>
 </clause><clause id="H3B111198D02A4333A2DA8BAB9CAD5892"><enum>(ii)</enum><text>by striking <quote>their children</quote> and inserting <quote>the children of such parent</quote>;</text> </clause></subparagraph></paragraph><paragraph id="H79D6A7AC94E4448DB69B7050D3D54719"><enum>(6)</enum><text>in subsection (f)(1), in the matter proceeding subparagraph (A) by inserting <quote>, Indian tribes, or tribal organizations</quote> after <quote>public or private entities</quote>;</text>
 </paragraph><paragraph id="H94F876166C704BA69ED7AD9DC835E805"><enum>(7)</enum><text>in subsection (g)—</text> <subparagraph id="H83617D5A86E84FF5958644FD077DB78B"><enum>(A)</enum><text>by striking <quote>identify women</quote> and inserting <quote>identify caregiver parents</quote>; and</text>
 </subparagraph><subparagraph id="HD8C8C5BE7789432B84768A743BCA8B5E"><enum>(B)</enum><text display-inline="yes-display-inline">by striking <quote>the women</quote> and inserting <quote>such parents</quote>;</text> </subparagraph></paragraph><paragraph commented="no" id="HDDF0F5F4F4274761909695C9CE47C5DA"><enum>(8)</enum><text>in subsection (h)(1), by striking <quote>pregnant and postpartum women</quote> and inserting <quote>caregiver parents</quote>;</text>
 </paragraph><paragraph commented="no" id="HC9AADFE3E8754C8F8417521CD08E72DE"><enum>(9)</enum><text>in subsection (j)—</text> <subparagraph id="HEB3E15C0D57445BCA48CD404AEA0A92E"><enum>(A)</enum><text display-inline="yes-display-inline">in the matter proceeding paragraph (1)—</text>
 <clause id="HC476FBF8F27B465FBC4AE448506A287E"><enum>(i)</enum><text>by striking <quote>to on behalf</quote> and inserting <quote>to or on behalf</quote>; and</text> </clause><clause id="H22EE909D34494C31810B73A0870BA4ED"><enum>(ii)</enum><text>by striking <quote>woman</quote> and inserting <quote>caregiver parent</quote>;</text>
 </clause></subparagraph><subparagraph id="H48DD5D7E44F64711B6F1B044E332458D"><enum>(B)</enum><text>in paragraph (2), by striking <quote>the woman</quote> and inserting <quote>such parent</quote>; and</text> </subparagraph><subparagraph id="H00F801234C2E46D6BFED6B645E70DD73"><enum>(C)</enum><text>in paragraph (3), by striking <quote>woman</quote> and inserting <quote>parent</quote>;</text>
 </subparagraph></paragraph><paragraph commented="no" id="HA6E63CC474F34987B73EB4AD4C4EB84B"><enum>(10)</enum><text>in subsection (k)(2), by striking <quote>women</quote> and inserting <quote>caregiver parents</quote>;</text> </paragraph><paragraph id="H60C8890D68424AFA8233DBBDF8CD9E7F"><enum>(11)</enum><text>in subsection (l), by striking <quote>such agreements</quote> and inserting <quote>the funding agreements under this section</quote>;</text>
 </paragraph><paragraph commented="no" display-inline="no-display-inline" id="H166B2B3CDF9A49B79E5913BEFDF768C8"><enum>(12)</enum><text>by amending subsection (m) to read as follows:</text> <quoted-block display-inline="no-display-inline" id="HE5A9790E4E3947E3B92EE02806B37D43" style="OLC"> <subsection commented="no" id="H9B1E350989634189B84F13B3837C8B74"><enum>(m)</enum><header>Use of funds; Priority for certain areas served</header> <paragraph commented="no" id="HFFC7EB7FBA694C10946D289DA2519E52"><enum>(1)</enum><header>Use of funds</header><text display-inline="yes-display-inline">A funding agreement for an award under subsection (a) for an applicant is that funds awarded under subsection (a) to such applicant shall be used for programs according to the following order of priority:</text>
 <subparagraph commented="no" id="H239B693BE20342C5BB26C9894259851B"><enum>(A)</enum><text>For a program that provides services to caregiver parents who are pregnant and postpartum women.</text> </subparagraph><subparagraph commented="no" id="H1F297882CA6842D3B653D3D1A0BBCE17"><enum>(B)</enum><text>For a program that provides services to caregiver parents who are single parents and the sole caregivers with respect to their children.</text>
 </subparagraph><subparagraph commented="no" id="HEB2A59B1D6874CEB9178EDDBA1D7AEC7"><enum>(C)</enum><text>For a program that provides services to any caregiver parents.</text> </subparagraph></paragraph><paragraph commented="no" id="HF6FB2669B19347C69A4E2E28380DD412"><enum>(2)</enum><header>Priority for certain areas served</header><text>In making awards under subsection (a), the Director shall give priority to any entity, tribe, or organization that agrees to use the award for a program serving an area that—</text>
 <subparagraph commented="no" id="H29CD4E939CA547829F62D7D725C93642"><enum>(A)</enum><text>is an area determined by the Director to have a shortage of family-based substance abuse treatment options; or</text>
 </subparagraph><subparagraph commented="no" id="HD42EF374F8D34D949A31BCC10B6A3D4B"><enum>(B)</enum><text display-inline="yes-display-inline">is determined by the Director to have high rates of addiction to heroin, opioids, cocaine, methamphetamine, 3,4-methylene­dioxy­meth­am­phet­amine, or phen­cy­cli­dine.</text></subparagraph></paragraph></subsection><after-quoted-block>;</after-quoted-block></quoted-block>
 </paragraph><paragraph commented="no" id="H14B44CD2D3864421A0700DC6DFDED28B"><enum>(13)</enum><text>in subsection (p)—</text> <subparagraph commented="no" id="HFA5606B4CFCC49EE90327B160382C9F3"><enum>(A)</enum><text>by striking <quote>October 1, 1994</quote> and inserting <quote>January 1, 2019</quote>;</text>
 </subparagraph><subparagraph id="HFA111012D1C645ACA0BD19968733A76A"><enum>(B)</enum><text>by striking <quote>Committee on Labor and Human Resources</quote> and inserting <quote>Committee on Health, Education, Labor, and Pensions</quote>; and</text> </subparagraph><subparagraph id="HFA205582B65D4454B458BC1D01ABC0CC"><enum>(C)</enum><text>by striking the third sentence;</text>
 </subparagraph></paragraph><paragraph commented="no" id="H0522FBDDFCBC43B4B7FA00E66A3CAEA2"><enum>(14)</enum><text>in subsection (q)—</text> <subparagraph commented="no" id="H6E092D0C619D4C8A9AC59C9F6E170C9F"><enum>(A)</enum><text>by redesignating paragraphs (2), (3), (4), and (5) as paragraphs (3), (4), (5), and (6), respectively;</text>
 </subparagraph><subparagraph commented="no" id="HAB42B27791C2483188A26F11AAB73AE0"><enum>(B)</enum><text>by inserting after paragraph (1) the following new paragraph:</text> <quoted-block display-inline="no-display-inline" id="H5A14EF67B5F143C5A7B2C43B9BD9F4EF" other-style="archaic" style="other"> <paragraph commented="no" id="HE9E1C542EB66482B93BBD7AC985B00B8"><enum>(2)</enum><text>The term <term>caregiver parent</term> means, with respect to a child, a parent or legal guardian with whom the child resides, and includes a pregnant woman.</text></paragraph><after-quoted-block>; and</after-quoted-block></quoted-block>
 </subparagraph><subparagraph commented="no" id="HA91777202A8947328366C98615F7EF85"><enum>(C)</enum><text>by amending paragraph (3), as redesignated by subparagraph (A) of this paragraph, to read as follows:</text>
					<quoted-block display-inline="no-display-inline" id="H1D34F07C435D4D7A849F9D5479634E1D" other-style="archaic" style="other">
 <paragraph commented="no" id="HB5A76CEC6E144B36A179EF69EDC77EF7"><enum>(3)</enum><text>The term <term>eligible caregiver parent</term> means a caregiver parent who has been admitted to a program operated pursuant to subsection (a).</text></paragraph><after-quoted-block>; and</after-quoted-block></quoted-block> </subparagraph></paragraph><paragraph commented="no" id="H07404CD0078749A0844F669BA76DAACA"><enum>(15)</enum><text>in subsection (r), by striking <quote>to fiscal years 2001 through 2003</quote> and inserting <italic></italic><quote>for fiscal years 2019 through 2023</quote>.</text>
			</paragraph></section><section display-inline="no-display-inline" id="H5E4C03C395544CC48233F2077F196CAA"><enum>5.</enum><header>Effectiveness of stimulant treatment methods</header>
 <subsection commented="no" id="HE95669720B8E4B6EA78357A9314A8705"><enum>(a)</enum><header>Research</header><text display-inline="yes-display-inline">The Director of the National Institute on Drug Abuse shall conduct research, directly or through contract with another entity, on the effectiveness of the use of agonist and antagonist drugs to reduce the problems associated with stimulant abuse, including cocaine and methamphetamine abuse.</text>
 </subsection><subsection commented="no" id="H515F154D2341467CB3804B191EA1F132"><enum>(b)</enum><header>Authorization of appropriations</header><text display-inline="yes-display-inline">There are authorized to be appropriated such sums as may be necessary to carry out this section for fiscal years 2019 through 2023.</text>
			</subsection></section><section id="H3DE56CA8F6264C5697F114B1BCB43DC3"><enum>6.</enum><header>IOM Study on drug treatments for stimulant abuse</header>
 <subsection id="H2B6D7F35CE944F45827F55E303B3072D"><enum>(a)</enum><header>Report</header><text display-inline="yes-display-inline">The Secretary of Health and Human Services shall seek to enter into a contract with the Institute of Medicine of the National Academies to complete a literature review and submit a report to Congress on the effectiveness of agonist and antagonist drugs for the treatment of stimulant abuse, including cocaine and methamphetamine abuse.</text>
 </subsection><subsection id="H5B96E3C863FB4748A82B529C2AEFD95B"><enum>(b)</enum><header>Authorization of appropriations</header><text display-inline="yes-display-inline">There are authorized to be appropriated such sums as may be necessary to carry out this section for fiscal years 2019 through 2023.</text>
			</subsection></section><section id="HC9196BA16FD94978A60ABFF880B5196C"><enum>7.</enum><header>GAO Evaluation of the impact of this legislation<editorial></editorial></header>
 <subsection id="H5620F51491A44C6BBF9077D36C5FA145"><enum>(a)</enum><header>Study on the level of funding for treatment</header><text display-inline="yes-display-inline">The Comptroller General of the United States shall conduct a study on—</text> <paragraph id="H94FEADFE5AE442B1A9FDA64BE7677E48"><enum>(1)</enum><text display-inline="yes-display-inline">the impact of the programs authorized by this Act (including the amendments made by this Act) on the effectiveness and availability of treatment for heroin, opioids, cocaine, methamphetamine, 3,4-methylene­dioxy­meth­am­phet­amine, and phen­cy­cli­dine abuse;</text>
 </paragraph><paragraph id="H7036CC566E5344E686E2E3B2A8C3624A"><enum>(2)</enum><text display-inline="yes-display-inline">whether the level of Federal funding available for the treatment of heroin, opioids, cocaine, methamphetamine, 3,4-methylene­dioxy­meth­am­phet­amine, and phen­cy­cli­dine abuse meets, exceeds, or is less than the amount necessary to provide adequate treatment for such abuse; and</text>
 </paragraph><paragraph id="HB23E228C4AB242659873ECC3E34F0A89"><enum>(3)</enum><text display-inline="yes-display-inline">the impact of effective treatment of heroin, opioids, cocaine, methamphetamine, 3,4-methylene­dioxy­meth­am­phet­amine, and phen­cy­cli­dine abuse on cost savings due to the reduced need for criminal justice and other services.</text>
				</paragraph></subsection><subsection id="H7BD7E473DBA54733AFB8DB4A898098D3"><enum>(b)</enum><header>Reports</header>
 <paragraph id="HCBA103FB154B470C82B782975F19B6CE"><enum>(1)</enum><header>Interim report</header><text>Not later than the last day of the two-year period beginning on the date of enactment of this Act, the Comptroller General shall submit to Congress a report on the interim findings of the study under <internal-xref idref="H5620F51491A44C6BBF9077D36C5FA145" legis-path="7.(a)">subsection (a)</internal-xref>.</text>
 </paragraph><paragraph id="H19F65E3D88364087AA36D2CB124666D2"><enum>(2)</enum><header>Final report</header><text display-inline="yes-display-inline">Not later than 3 years after the date on which the report under <internal-xref idref="HCBA103FB154B470C82B782975F19B6CE" legis-path="7.(b)(1)">paragraph (1)</internal-xref> is submitted to Congress, the Comptroller General shall submit to Congress a report on the findings of the study under <internal-xref idref="H5620F51491A44C6BBF9077D36C5FA145" legis-path="7.(a)">subsection (a)</internal-xref>.</text>
 </paragraph></subsection></section><section id="H48CD48D081D8461E9B78EB2FFD7F1634"><enum>8.</enum><header>No additional appropriations</header><text display-inline="no-display-inline">This Act, and the amendments made by this Act, shall not be construed to increase the amount of appropriations that are authorized to be approved for any fiscal year.</text>
		</section></legis-body></bill>


